SA4503 8-Week Study in Major Depressive Disorder (MDD)

Summary

The purpose of this study is to determine the efficacy of SA4503 compared to placebo in the treatment of subjects with major depressive disorder (MDD). Secondary, to evaluate the safety of SA4503 compared to placebo in subjects with MDD.

Timeline

Start

2007-11

Primary completion

—

Completion

2008-09

Drugs

Indications